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Telemedicine in response to challenges  
of modern diabetology
ABSTRACT
Due to the steadily increasing number of patients 
with diabetes all over the world, access to specialist 
diabetes care is becoming difficult, especially in rural 
areas. Approximately 30% of diabetic patients do not 
achieve the target blood glucose values, which is cer-
tainly an important problem of modern diabetology, 
because it translates into late vascular complications 
of diabetes, lower quality of life and premature death. 
In response to the raising demand for diabetes care, 
technological solutions increasing the accessibility to 
healthcare professionals with a concomitant reduction 
of costs of such care may be very useful. In a view of 
the above, the contribution of continuously developing 
widely understood information and communication 
technologies (ICT) to an improvement of blood glucose 
control in diabetic patients has been recently evaluated 
in research studies. Phone consultations, remote blood 
glucose levels monitoring and video consultations are 
the most commonly studied telemedical interventions. 
Each of them leads to an increased accessibility to 
specialist diabetes care. Besides clinical trials, in real 
patients’ life there are many mobile health applica-
tions (apps) available which may be helpful in daily life 
diabetes management however raise concerns about 
regulation and approval, privacy, accuracy and safety. 
Contrary to cardiology, telemedical solutions in diabe-
tology are not popular for commercial use yet, which is 
why patients and their physicians still have to wait for 
standardisation and appropriate legal regulations for 
telemedical interventions in diabetes care. Although as 
evidenced by clinical trials, such interventions translate 
into improved blood glucose control, lower costs of 
diabetes care and even a reduction of hypoglycaemia 
risk. (Clin Diabet 2016; 5, 1: 22–25)
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Introduction
Currently, over 366 million people in the world 
are estimated to have diabetes, and 552 million (what 
translates to 9.9% of the world population) will have 
diabetes by 2030 [1]. Treatment of diabetes and its com-
plications is extremely expensive and imposes a con-
siderable economic burden on healthcare. The disease 
is incurable but optimal control of blood glucose level 
enables minimisation of the risk of complications [2]. 
Apparently, less than 70% of diabetic patients achieve 
the target blood glucose values, which indicates that 
effective diabetes treatment remains a challenge 
for modern diabetology [3]. In a view of the raising 
number of diabetic patients, whose life span has been 
increasing owing to the advancements in medicine and 
pharmacy, the access to specialist care becomes more 
and more difficult, especially among the inhabitants 
of rural areas. On the other hand, the more difficult 
access to diabetes care is partially responsible for worse 
metabolic control in diabetic patients and for the oc-
currence of diabetic complications. In response to the 
increasing demand for diabetes care, technological 
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solutions spreading the accessibility to healthcare 
professionals with a concomitant reduction of costs 
of such care could be useful [4].
Like other life domains, also medicine could not 
resist the influence of the ubiquitously present in-
ternet. In the recent years, more and more so-called 
“e-services”, including e-health, have been appearing 
in the world; they combine the use of the internet 
and other related technologies in healthcare. Initially, 
World Health Organization (WHO) referred to remote 
medical activities as medical telematics, while cur-
rently the “telemedicine” term concentrates also on 
remote medical education (remote teaching) apart 
from therapeutic aspects or “mHealth” that stands 
for mobile health.
Telemedicine means remote provision of health-re-
lated services with the use of telecommunication tech-
nologies such as phones or the internet. Mobile health 
is defined as “mobile computing, medical sensor, and 
communications technologies” that enhance chronic 
diseases beyond the traditional outpatient physician-
-patient encounter. Some of the services require direct 
involvement of patients and healthcare professionals, 
other only passively collect blood glucose data and 
transfer them to specialists for evaluation [5, 6]. 
In 2009, “The Economist” reported that posses-
sion of a mobile phone had contributed to a greater 
and faster change in life of a larger number of people 
than any other technology. In many countries in Europe 
almost 100 per cent of the population possesses a mo-
bile phone. Moreover, recently also smartphones and 
tablets have been contributing to a change in lifestyle, 
work and play. However, legal, social and political regu-
lations do not keep up with those changes, although 
the decision-makers are aware of the benefit potential 
and draw upon those benefits. The healthcare system is 
no exception and the use of modern technologies also 
can bring huge benefits [7]. In an article from 2014, 
members of the International Diabetes Federation (IDF) 
emphasise the fact that patients with diabetes require 
constant discipline, and wide access to specialist in-
formation about their disease is beneficial. Diabetic 
patients contact a diabetologist for 10 hours in a year 
on average, and for the remaining amount of time the 
patients are left on their own. However, they usually 
have a mobile phone with them which is currently used 
not only for phone communication but is often an on-
going source of information, entertainment, education, 
social meetings and other services. Introducing such 
a tool into the healthcare system could improve access 
to medical knowledge and care [7]. The present article 
presents selected telemedical or mHealth tools which 
may find their place in diabetology care.
Teleconferences
In a view of the insufficient number of specialist 
physicians, especially in rural areas, and the increasing 
prevalence of type 2 diabetes, medical video consul-
tations based on the video conference principle may 
constitute a potential solution to geographical barriers 
limiting access to specialist medical care. There were 
some studies trying to use various of teleconference 
models, but the data on the effectiveness of this ap-
proach measured by a significant reduction of the 
HbA1c value are insufficient. These studies either did 
not take into account HbA1c values or did not include 
the assessment of a control group or demonstrated 
only a very small difference in HbA1c reduction (0.32%) 
[8–11]. Additionally, often no physician but only an 
educator participated in the research. Only as recently 
as in 2014, the TREAT (Telemedicine for Reach, Educa-
tion, Access, and Treatment) study was published in 
Diabetes Care. The study demonstrated a significant 
improvement in metabolic control of diabetes owing 
to the use of teleconsultations. That study assessed the 
efficacy of combining video consultations conducted 
by an endocrinologist from an urban centre collaborat-
ing with a local diabetes educator in reducing HbA1c 
in persons inhabiting rural areas. Patients with type 2 
diabetes with poor metabolic control (HbA1c > 7.0%), 
who had difficulty in access to specialist medical care 
because of their place of residence, were enrolled in the 
study. Thanks to a diabetes nurse (educator), patients 
attended a video consultation every three months for 
half a year. HbA1c was measured at 3 and 6 months 
after the onset of treatment and compared with the 
control group of persons who received standard 
treatment within the framework of routine primary 
medical care. The persons receiving telemedical care 
were demonstrated to have better metabolic control 
of diabetes in comparison with the persons receiving 
standard care, after adjustment for insulin use, sex, 
age, BMI and duration of diabetes. In 84% of study 
subjects, therapy had to be intensified (by initiating 
insulin therapy, adding another insulin formulation, or 
increasing the total daily insulin dose or oral agents). 
Ninety-three per cent of the subjects adhered to self-
monitoring of blood glucose recommendations. The 
mean incidence of hypoglycaemia was 1.7/30 days; 
mild cases were a majority and severe hypoglycaemia 
was rare, which indicates the safety of this method of 
medical consultations [12].
Remote blood glucose monitoring  
and insulin dose titration
Self-monitoring of blood glucose by the patient 
is an essential factor that enables diabetic patients 
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to obtain good metabolic control of their disease. Up 
to not so long ago, patients had to keep the so-called 
blood glucose self-monitoring diaries in the paper form, 
and currently the advancement in glucose meters and 
remote technologies has made it possible to record 
measurements made on glucose meters in the electronic 
form, and have them analysed by a diabetologist dur-
ing or before the visit at the Diabetes Clinic. Regardless 
of diabetes treatment with oral medicines or insulin, 
patients conducting self-monitoring of blood glucose 
were demonstrated to obtain lower HbA1c values [13].
Insulin treated patients need insulin adjustment 
according to their blood glucose levels but face-to-face 
visits are time consuming and associated with absence 
form work for occupationally active persons what 
could be troublesome especially for those of low socio-
economic status. One of the randomised clinical trials 
initiated in 2013 including 61 low income, urban (New 
York) patients with type 2 diabetes aimed to evaluate 
effectiveness of remote advice of how to titrate basal 
insulin throughout a short messages services (SMS) text 
messaging and phone calls a well as cost savings and 
patients satisfaction of this intervention. It was proven 
that significantly greater proportion of patients in the 
interventional arm reached their optimal basal insulin 
dose than patient in the usual care arm. Additionally 
the intervention was feasible and cot saving in mean-
ing of patients time who could titrate their insulin dose 
without multiple clinic visits [14].
Applications in mobile devices
In 2011, the TELEDIAB-1 study was published in 
Diabetes Care. The study demonstrated that the use of 
the Diabeo system (a smartphone coupled to a web-
site), in which the insulin dose was proposed automati-
cally and results were controlled at a teleconsultation 
in patients with type 1 diabetes, led to a reduction of 
HbA1c values by 0.9% within half a year in comparison 
with a control group receiving standard treatment 
[15]. A post hoc analysis of that study was published in 
2014 and confirmed usefulness of the system however 
a bigger study involving 700 patients from 100 diabe-
tes centres for a period of 2 years is planned in order 
to obtain reimbursable status for Diabeo system from 
French National Health Insurance system [16]. Waki et 
al. studied an application named DialBetics in which 
one of the examined functions was food recording 
with the use of a multimedia food record, FoodLog. 
A dietitian who analysed obtained information advised 
the diabetic patient about diet modifications. The 
meal–photo function providing patients with real-time 
support for diet modification has been shown to be an 
effective and convenient tool [17]. 
A very important element of remote monitoring 
of blood glucose in patients with type 1 diabetes is 
reducing the incidence of hypoglycaemia episodes, 
which are often a barrier in attaining diabetes treat-
ment targets [17–19]. An interesting solution has been 
proposed by Rossi et al. who studied smartphone 
application named “Diabetes Interactive Diary” (DID) 
which is a carbohydrate/bolus calculator promoting 
the patient-physician communication via SMS among 
127 patients not previously educated on carbohydrate 
counting who were randomly assessed to a DID group 
or traditional education group. 6 months of applica-
tion usage resulted in reduced risk of moderate/severe 
hypoglycaemia and improved quality of life [18]. 
Currently, there are many medical applications 
freely available for mobile devices that enable the 
control of self-measurements of blood glucose level 
but they are not synchronised with other devices or 
IT systems nor standardised. Therefore, international 
standardisation organisations such as IEEE 11073 PHD 
WG (Personal Health Working GROUP) or Health Level 
Seven (HL7) created ISO/IEEE 11073 and the Continu-
ity of Care Document (CCD), to ensure compatibility 
between personal medical devices and the medical 
information system and thus to reduce healthcare costs 
and concomitantly increase the quality of treatment. 
Personal data from glucose meters should be gener-
ated in the form of standard reports which can be sent 
between medical centres. It is necessary to create an ap-
plication connected to a glucose meter and to conduct 
large-scale studies evaluating the usefulness of such 
applications for patients and healthcare professionals 
with a view to improve blood glucose control [20].
Summary
In the world, the number of patients with type 1 
and type 2 diabetes has been steadily increasing, which 
has made access to a diabetes specialist and education 
quite frequently limited. Both the healthcare system 
and the patients themselves are to blame for this situ-
ation. Firstly, not in all regions of the countries there 
is a sufficient number of diabetologists. Secondly, at 
least in Poland, only limited number of patients envis-
aged by the National Health Fund can be admitted to 
diabetes out patient clinics. Thirdly, the limited possibil-
ity of undergoing a diabetes consultation is associated 
with the patients themselves and their lack of time or 
difficulties with travelling to a physician because due 
to inability to be absent from work or due to physical 
disability to move.
Poorly managed diabetes, and thus chronic hyper-
glycaemia, inevitably leads to vascular complications of 
diabetes and consequentially to disabilities and pre-
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mature deaths, most commonly due to cardiovascular 
causes. Many of the patients do not achieve adequate 
metabolic control of the disease, which is frequently 
associated with the lack of diabetes education or access 
to diabetes consultations. No even the most modern 
medicines or medical devices (glucose meters or insulin 
pumps) will contribute to improved metabolic control 
of diabetes without proper diabetes education and su-
pervision by the diabetologist conducting the treatment.
The novel options of supervising the treatment 
of diabetic patients with the use of telemedical or so 
called mHealth methods, without the need for personal 
visits at the diabetes clinic, and of obtaining diabetes 
education on-line (e-education) make it possible to 
improve blood glucose control and quality of life of 
a large number of young diabetic patients without 
adequate metabolic control so far.
In the era of smartphones and general internet 
access popularisation of telemedical solutions may in 
the future become a method to improve glycaemic 
control of persons who have difficult access to diabe-
tologists because of their place of residence, type of 
work or motor disabilities, making it difficult for them 
to personally visit a physician at a Diabetes Clinic. Pa-
tients from rural areas often have to cover distances of 
many kilometres to undergo a consultation, which is 
associated with higher costs for the patients and with 
absenteeism from work. 
On the other hand, besides clinical trials where 
telemedical solutions are widely used, international 
diabetes societies currently do not recommend the 
use of diabetic telecare in the daily life due to the lack 
of authorisation and standardisation of telemedical 
services. Most applications that appear in the market 
are not accepted by the Food and Drug Administration 
because they are non-compliant with the guidelines 
issued in 2011 by FDA. It should also be borne in mind 
that smartphone applications and other forms of tel-
emedicine will not replace an assessment by a clinician 
and may only be a helpful tool in diabetes control. 
Disclosure: none
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